- Home
- IMUX vs FRAF Comparison
IMUX vs FRAF Comparison
Compare IMUX & FRAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- FRAF
- Stock Information
- Founded
- IMUX 2016
- FRAF 1906
- Country
- IMUX United States
- FRAF United States
- Employees
- IMUX N/A
- FRAF N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- FRAF Major Banks
- Sector
- IMUX Health Care
- FRAF Finance
- Exchange
- IMUX Nasdaq
- FRAF Nasdaq
- Market Cap
- IMUX 131.5M
- FRAF 127.4M
- IPO Year
- IMUX N/A
- FRAF N/A
- Fundamental
- Price
- IMUX $1.34
- FRAF $32.20
- Analyst Decision
- IMUX Strong Buy
- FRAF
- Analyst Count
- IMUX 4
- FRAF 0
- Target Price
- IMUX $12.75
- FRAF N/A
- AVG Volume (30 Days)
- IMUX 263.6K
- FRAF 3.1K
- Earning Date
- IMUX 08-08-2024
- FRAF 10-22-2024
- Dividend Yield
- IMUX N/A
- FRAF 3.98%
- EPS Growth
- IMUX N/A
- FRAF N/A
- EPS
- IMUX N/A
- FRAF 3.11
- Revenue
- IMUX N/A
- FRAF $69,344,000.00
- Revenue This Year
- IMUX N/A
- FRAF N/A
- Revenue Next Year
- IMUX N/A
- FRAF N/A
- P/E Ratio
- IMUX N/A
- FRAF $10.36
- Revenue Growth
- IMUX N/A
- FRAF 3.47
- 52 Week Low
- IMUX $0.95
- FRAF $25.11
- 52 Week High
- IMUX $1.92
- FRAF $35.00
- Technical
- Relative Strength Index (RSI)
- IMUX 45.28
- FRAF 71.24
- Support Level
- IMUX $1.38
- FRAF $31.51
- Resistance Level
- IMUX $1.56
- FRAF $32.73
- Average True Range (ATR)
- IMUX 0.12
- FRAF 0.36
- MACD
- IMUX -0.02
- FRAF 0.19
- Stochastic Oscillator
- IMUX 9.09
- FRAF 83.89
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About FRAF Franklin Financial Services Corporation
Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals, and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.